204 related articles for article (PubMed ID: 20525690)
1. Structural characterization of HIV gp41 with the membrane-proximal external region.
Shi W; Bohon J; Han DP; Habte H; Qin Y; Cho MW; Chance MR
J Biol Chem; 2010 Jul; 285(31):24290-8. PubMed ID: 20525690
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
3. Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation.
Liu J; Deng Y; Dey AK; Moore JP; Lu M
Biochemistry; 2009 Apr; 48(13):2915-23. PubMed ID: 19226163
[TBL] [Abstract][Full Text] [Related]
4. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
[TBL] [Abstract][Full Text] [Related]
6. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
7. In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes.
Lapelosa M; Gallicchio E; Arnold GF; Arnold E; Levy RM
J Mol Biol; 2009 Jan; 385(2):675-91. PubMed ID: 19026659
[TBL] [Abstract][Full Text] [Related]
8. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.
Dennison SM; Stewart SM; Stempel KC; Liao HX; Haynes BF; Alam SM
J Virol; 2009 Oct; 83(19):10211-23. PubMed ID: 19640992
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.
Habte HH; Banerjee S; Shi H; Qin Y; Cho MW
Virology; 2015 Dec; 486():187-97. PubMed ID: 26454663
[TBL] [Abstract][Full Text] [Related]
10. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.
Wang J; Tong P; Lu L; Zhou L; Xu L; Jiang S; Chen YH
PLoS One; 2011 Mar; 6(3):e18233. PubMed ID: 21483871
[TBL] [Abstract][Full Text] [Related]
12. A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies.
Pejchal R; Gach JS; Brunel FM; Cardoso RM; Stanfield RL; Dawson PE; Burton DR; Zwick MB; Wilson IA
J Virol; 2009 Sep; 83(17):8451-62. PubMed ID: 19515770
[TBL] [Abstract][Full Text] [Related]
13. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
Dawood R; Benjelloun F; Pin JJ; Kone A; Chanut B; Jospin F; Lucht F; Verrier B; Moog C; Genin C; Paul S
AIDS; 2013 Mar; 27(5):717-30. PubMed ID: 23719346
[TBL] [Abstract][Full Text] [Related]
14. Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.
Banerjee S; Shi H; Habte HH; Qin Y; Cho MW
Virology; 2016 Mar; 490():17-26. PubMed ID: 26803471
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.
Montero M; Gulzar N; Klaric KA; Donald JE; Lepik C; Wu S; Tsai S; Julien JP; Hessell AJ; Wang S; Lu S; Burton DR; Pai EF; Degrado WF; Scott JK
J Virol; 2012 Mar; 86(6):2930-41. PubMed ID: 22238313
[TBL] [Abstract][Full Text] [Related]
16. The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide.
Noah E; Biron Z; Naider F; Arshava B; Anglister J
Biochemistry; 2008 Jul; 47(26):6782-92. PubMed ID: 18540633
[TBL] [Abstract][Full Text] [Related]
17. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
Wahome N; Pfeiffer T; Ambiel I; Yang Y; Keppler OT; Bosch V; Burkhard P
Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.
Buzon V; Natrajan G; Schibli D; Campelo F; Kozlov MM; Weissenhorn W
PLoS Pathog; 2010 May; 6(5):e1000880. PubMed ID: 20463810
[TBL] [Abstract][Full Text] [Related]
19. Designing a soluble near full-length HIV-1 gp41 trimer.
Gao G; Wieczorek L; Peachman KK; Polonis VR; Alving CR; Rao M; Rao VB
J Biol Chem; 2013 Jan; 288(1):234-46. PubMed ID: 23184960
[TBL] [Abstract][Full Text] [Related]
20. Progress towards the development of a HIV-1 gp41-directed vaccine.
McGaughey GB; Barbato G; Bianchi E; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller MD; Pessi A; Shiver JW; Bogusky MJ
Curr HIV Res; 2004 Apr; 2(2):193-204. PubMed ID: 15078183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
